Literature DB >> 11496304

Detection of Epstein-Barr virus in gastrectomy specimens.

Y A Luqmani1, S O Linjawi, S Shousha.   

Abstract

Epstein Barr virus (EBV) has been reported to be present in a minority of gastric carcinomas and may be implicated in its pathogenesis. This study was aimed at determining the occurrence of EBV in 43 consecutive gastrectomy specimens with a variety of benign and malignant lesions. In situ hybridisation was used for detection of EBER RNA, the marker for latent EBV infection. Only 1/20 (5%) gastric cancers was EBER positive; a moderately differentiated adenocarcinoma with a heavy lymphocytic infiltration. The interstitial lymphocytic infiltrate was predominantly of B cell type, but the majority of lymphocytes overlying the tumour cells were CD8+ T cells. The other gastric lesions examined, which included 15 peptic ulcers, 6 stromal tumours and 2 lymphomas, were all EBER negative. Using a biotin detection system, scattered EBER positive cells were seen in adjacent normal gastric and/or duodenal mucosa in 9 sections from 8 cases (i.e., in 19% of all 43 cases examined). However, on using a digoxygenin detection system, no reactivity was found in these normal cells. An immunoperoxidase stain for chromogranin A showed that these apparently 'EBER positive' cells corresponded to normal chromogranin positive neuroendocrine cells within the gastric and duodenal mucosa. We conclude that EBV infection occurred only in the lymphoepithelioma type of gastric carcinoma and was absent from the other adenocarcinomas and from normal and benign tissues. The occasional EBER positive reaction encountered in normal cells was probably the result of a false signal arising from neuroendocrine cells as a consequence of the biotin-containing detection system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11496304     DOI: 10.3892/or.8.5.995

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  Co-infection with Helicobacter pylori and Epstein-Barr virus in benign upper digestive diseases: An endoscopic and serologic pilot study.

Authors:  György M Buzás; Judith Konderák
Journal:  United European Gastroenterol J       Date:  2015-10-13       Impact factor: 4.623

2.  Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa.

Authors:  Julie L Ryan; You-Jun Shen; Douglas R Morgan; Leigh B Thorne; Shannon C Kenney; Ricardo L Dominguez; Margaret L Gulley
Journal:  Dig Dis Sci       Date:  2012-03-13       Impact factor: 3.199

3.  Epstein-Barr virus is absent in gastric superficial neoplastic lesions.

Authors:  Joana Ribeiro; Mariana Malta; Ana Galaghar; Luís Pedro Afonso; Diogo Libânio; Rui Medeiros; Mario Dinis-Ribeiro; Pedro Pimentel-Nunes; Hugo Sousa
Journal:  Virchows Arch       Date:  2019-11-01       Impact factor: 4.064

Review 4.  Epstein-Barr Virus and Gastric Cancer Risk: A Meta-analysis With Meta-regression of Case-control Studies.

Authors:  Jong-Myon Bae; Eun Hee Kim
Journal:  J Prev Med Public Health       Date:  2016-03-04

Review 5.  Epstein-Barr virus infection and gastric cancer: a systematic review.

Authors:  Xin-Zu Chen; Hongda Chen; Felipe A Castro; Jian-Kun Hu; Hermann Brenner
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis.

Authors:  Ahmad Tavakoli; Seyed Hamidreza Monavari; Farid Solaymani Mohammadi; Seyed Jalal Kiani; Saber Armat; Mohammad Farahmand
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.